Gene · 6007
Papers4,511
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,511
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The impact of ABO and RhD blood types on Babesia microti infection. | PLoS Negl Trop Dis | 2023 | 36696414 | PubTator, text mining | PubMed |
| Small Molecule Drugs That Inhibit Phagocytosis. | Molecules | 2023 | 36677815 | PubTator, text mining | PubMed |
| Evaluation of Different Cannulation Strategies for Aortic Arch Surgery Using a Cardiovascular Numerical Simulator. | Bioengineering (Basel) | 2023 | 36671632 | PubTator, text mining | PubMed |
| How we treat primary immune thrombocytopenia in adults. | J Hematol Oncol | 2023 | 36658588 | PubTator, text mining | PubMed |
| Patients with Asian-type DEL can safely be transfused with RhD-positive blood. | Blood | 2023 | 36638337 | PubTator, text mining | PubMed |
| Prediction of pre-hospital blood transfusion in trauma patients based on scoring systems. | BMC Emerg Med | 2023 | 36635632 | PubTator, text mining | PubMed |
| Rhesus Negativity Prevalence and Neonatal Outcomes among Pregnant Women Delivered at Bule Hora University Teaching Hospital, West Guji Zone, South Ethiopia. | Clin Med Insights Pediatr | 2023 | 36632148 | PubTator, text mining | PubMed |
| Management of Wrong Blood Transfusion to an RhD Negative Woman in Labor. | Int J Womens Health | 2023 | 36628052 | PubTator, text mining | PubMed |
| Platinum-Based Regimens Are Active in Advanced Pediatric-Type Rhabdomyosarcoma in Adults and Depending on HMGB1 Expression. | Int J Mol Sci | 2023 | 36614297 | PubTator, text mining | PubMed |
| Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape. | BMC Pregnancy Childbirth | 2023 | 36611144 | PubTator, text mining | PubMed |
| Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma. | Hematology | 2023 | 36607150 | PubTator, text mining | PubMed |
| Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time. | Cancer Res | 2023 | 36603130 | PubTator, text mining | PubMed |
| Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression. | Nat Biotechnol | 2023 | 36593395 | PubTator, text mining | PubMed |
| A wrist band for patients who receive group "O" RhD-positive whole blood in the field. | Transfusion | 2023 | 36576092 | PubTator, text mining | PubMed |
| Reassessment of Critical Anti-D Antibody Titer in RhD Alloimmunized Antenatal Women. | Lab Med | 2023 | 36539334 | PubTator, text mining | PubMed |
| What attributes influence rural household's willingness to get vaccinated for COVID-19? Perspectives from six Chinese townships. | Vaccine | 2023 | 36535824 | PubTator, text mining | PubMed |
| The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees. | EBioMedicine | 2023 | 36529104 | PubTator, text mining | PubMed |
| Factors influencing plasma donation behavior of COVID-19 recovered patients in Bangladesh: A pilot study. | Health Sci Rep | 2023 | 36479388 | PubTator, text mining | PubMed |
| Donor and non-donor perspectives on receiving information from routine genomic testing of donor blood. | Transfusion | 2023 | 36478364 | PubTator, text mining | PubMed |
| History and current standard of postnatal management in hemolytic disease of the fetus and newborn. | Eur J Pediatr | 2023 | 36469119 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6007/papers?page=33